Bellinger Andrew
Insider CIK 1864116 · VERV Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 180,000 | — | $0 | 180,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2024-02-14 | 2024-02-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2023-02-14 | 2023-02-16 | 182,800 | — | $0 | 182,800 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-12-14 | 2022-12-16 | 36,000 | — | $0 | 179,994 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-12-14 | 2022-12-16 | 36,000 | $2.87 | $103.3K | 42,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-12-01 | 2022-12-02 | 865 | $22.95 | $19.9K | 6,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-10-28 | 2022-11-01 | 10,000 | — | $0 | 86,995 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-10-28 | 2022-11-01 | 10,000 | $1.48 | $14.8K | 16,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-10-28 | 2022-11-01 | 10,000 | $39.90 | $399.0K | 6,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-09-23 | 2022-09-27 | 40,000 | — | $0 | 96,995 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-09-23 | 2022-09-27 | 20,000 | — | $0 | 23,198 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-09-23 | 2022-09-27 | 20,000 | $1.48 | $29.6K | 26,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-09-23 | 2022-09-27 | 6,632 | $34.67 | $229.9K | 19,997 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-09-23 | 2022-09-27 | 13,368 | $35.59 | $475.8K | 6,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-09-23 | 2022-09-27 | 40,000 | $1.48 | $59.2K | 46,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-09-23 | 2022-09-27 | 36,798 | $35.31 | $1.30M | 9,831 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-09-23 | 2022-09-27 | 3,202 | $36.03 | $115.4K | 6,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-07-20 | 2022-07-22 | 20,000 | — | $0 | 1,599 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-07-20 | 2022-07-22 | 20,000 | $1.39 | $27.8K | 26,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-07-20 | 2022-07-22 | 20,000 | $34.90 | $698.0K | 6,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2022-07-13 | 2022-07-15 | 10,000 | — | $0 | 136,995 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2022-07-13 | 2022-07-15 | 10,000 | $1.48 | $14.8K | 16,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2022-07-13 | 2022-07-15 | 10,000 | $24.90 | $249.0K | 6,629 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise deriv | 2021-12-22 | 2021-12-27 | 15,000 | — | $0 | 146,995 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 4,871 | $39.37 | $191.8K | 5,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 8,161 | $38.60 | $315.0K | 9,871 | SEC↗ |
| VERV Verve Therapeutics, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 1,968 | $37.42 | $73.6K | 18,032 | SEC↗ |
| VERV Verve Therapeutics, Inc. | M Exercise | 2021-12-22 | 2021-12-27 | 15,000 | $1.48 | $22.2K | 20,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2021-12-16 | 2021-12-17 | 55,000 | — | $0 | 55,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | P Buy | 2021-06-21 | 2021-06-21 | 5,000 | $19.00 | $95.0K | 5,000 | SEC↗ |
| VERV Verve Therapeutics, Inc. | A Award deriv | 2021-06-17 | 2021-06-21 | 21,599 | — | $0 | 21,599 | SEC↗ |